Ausgabe 7/2016
Inhalt (25 Artikel)
Membrane microparticles: shedding new light into cancer cell communication
Paloma Silva de Souza, Roberta Soares Faccion, Paula Sabbo Bernardo, Raquel Ciuvalschi Maia
Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer
Mei Xue, Wei Chen, Xu Li
The difference in Ezrin–pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung
Kazunori Hata, Junji Yoshida, Hibiki Udagawa, Hiroko Hashimoto, Satoshi Fujii, Tomoyuki Hishida, Takeshi Kuwata, Keiju Aokage, Motohiro Kojima, Atsushi Ochiai, Kenji Suzuki, Masahiro Tsuboi, Genichiro Ishii
Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497
Lin Liu, Lin Chen, Xuan Wu, Xiang Li, Yang Song, Qian Mei, Jing Nie, Weidong Han
Improved survival boosts the prevalence of chronic myeloid leukemia: predictions from a population-based study
Michael Lauseker, Roman Gerlach, Martin Tauscher, Joerg Hasford
Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells
Hui Hui, Xiaoxiao Zhang, Hui Li, Xiao Liu, Le Shen, Yu Zhu, Jingyan Xu, Qinglong Guo, Na Lu
The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study
Debra E. Lyon, Ronald Cohen, Huaihou Chen, Debra L. Kelly, Angela Starkweather, Hyo-Chol Ahn, Colleen K. Jackson-Cook
Rapid staining and imaging of subnuclear features to differentiate between malignant and benign breast tissues at a point-of-care setting
Jenna L. Mueller, Jennifer E. Gallagher, Rhea Chitalia, Marlee Krieger, Alaattin Erkanli, Rebecca M. Willett, Joseph Geradts, Nimmi Ramanujam
Clonal heterogeneity in osteogenic potential of lung cancer-associated fibroblasts: promotional effect of osteogenic progenitor cells on cancer cell migration
Yoshitaka Suda, Shinya Neri, Hiroko Hashimoto, Youichi Higuchi, Masayuki Ishibashi, Masato Sugano, Kenkichi Masutomi, Masahiro Tsuboi, Atsushi Ochiai, Genichiro Ishii
Exploring an herbal “wonder cure” for cancer: a multidisciplinary approach
Eran Ben-Arye, Jamal Mahajna, Radi Aly, Mohammed Saleem Ali-Shtayeh, Yedidia Bentur, Efraim Lev, Gary Deng, Noah Samuels
Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer
Maria Luisa Gasparri, Giovanni Grandi, Daniele Bolla, Beat Gloor, Sara Imboden, Pierluigi Benedetti Panici, Michael D. Mueller, Andrea Papadia
Is there evidence for a better health care for cancer patients after a second opinion? A systematic review
Dana Ruetters, Christian Keinki, Sarah Schroth, Patrick Liebl, Jutta Huebner
Parotid melanoma of unknown primary
Jeffrey F. Scott, Cheryl L. Thompson, Ritva Vyas, Kord Honda, Chad Zender, Rod Rezaee, Pierre Lavertu, Henry Koon, Kevin D. Cooper, Meg R. Gerstenblith
Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia
Qian Jiang, Zheng-Chen Liu, Song-Xin Zhang, Robert Peter Gale
Molecular monitoring of tyrosine kinase inhibitor therapy of chronic myeloid leukemia in China
Qian Jiang, Robert Peter Gale
Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms
Kazuhiro Yoshida, Takeshi Nagasaka, Yuzo Umeda, Takehiro Tanaka, Keisuke Kimura, Fumitaka Taniguchi, Tomokazu Fuji, Kunitoshi Shigeyasu, Yoshiko Mori, Hiroyuki Yanai, Takahito Yagi, Ajay Goel, Toshiyoshi Fujiwara
Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer
Jing-wei Fu, Ying Kong, Xu Sun
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma
Niklas Schäfer, Gerrit H. Gielen, Sied Kebir, Anja Wieland, Andreas Till, Frederic Mack, Christina Schaub, Theophilos Tzaridis, Roman Reinartz, Michael Niessen, Rolf Fimmers, Matthias Simon, Christoph Coch, Christine Fuhrmann, Ulrich Herrlinger, Björn Scheffler, Martin Glas
Interstitial growth as an aggressive growth pattern in primary lung cancer
Shigeki Suzuki, Keiju Aokage, Tomoyuki Hishida, Junji Yoshida, Takeshi Kuwata, Chisako Yamauchi, Masahiro Tsuboi, Genichiro Ishii
Testicular seminoma clinical stage 1: treatment outcome on a routine care level
Klaus-Peter Dieckmann, Inken Dralle-Filiz, Cord Matthies, Julia Heinzelbecker, Jens Bedke, Jörg Ellinger, Petra Anheuser, Rainer Souchon, Uwe Pichlmeier
High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes
Natsuo Tomita, Norihito Soga, Yuji Ogura, Norio Hayashi, Takumi Kageyama, Makoto Ito, Yutaro Koide, Maiko Yoshida, Kana Kimura, Chiyoko Makita, Hiroyuki Tachibana, Takeshi Kodaira
A novel genetic score model of UGT1A1 and TGFB pathway as predictor of severe irinotecan-related diarrhea in metastatic colorectal cancer patients
Jing Li, Qianqian Yu, Shengling Fu, Min Xu, Tao Zhang, Conghua Xie, Jueping Feng, Jigui Chen, Aihua Zang, Yixin Cai, Qiang Fu, Shan Liu, Mingsheng Zhang, Qiu Hong, Liu Huang, Xianglin Yuan
Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?
Toshio Kato, Masahiro Morise, Masahiko Ando, Eiji Kojima, Tomohiko Ogasawara, Ryujiro Suzuki, Joe Shindoh, Masami Matsumoto, Yasuteru Sugino, Masahiro Ogawa, Yasuhiro Nozaki, Tetsunari Hase, Masashi Kondo, Hiroshi Saito, Yoshinori Hasegawa
EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia
Vivien Schäfer, Jana Ernst, Jenny Rinke, Nils Winkelmann, James F. Beck, Andreas Hochhaus, Bernd Gruhn, Thomas Ernst
Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy
Chunwoo Lee, Dalsan You, Sangjun Yoo, Cheryn Song, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim